vs
ASSOCIATED BANC-CORP（ASB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
ASSOCIATED BANC-CORP的季度营收约是REPLIGEN CORP的1.9倍（$383.0M vs $197.9M），ASSOCIATED BANC-CORP净利率更高（31.2% vs 6.7%，领先24.5%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.1%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ASB vs RGEN — 直观对比
营收规模更大
ASB
是对方的1.9倍
$197.9M
净利率更高
ASB
高出24.5%
6.7%
两年增速更快
RGEN
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $197.9M |
| 净利润 | $119.6M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 31.2% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | 566.6% | 143.9% |
| 每股收益（稀释后） | $0.70 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBRGEN
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | $197.9M | ||
| Q3 25 | $305.2M | $188.8M | ||
| Q2 25 | $300.0M | $182.4M | ||
| Q1 25 | $285.9M | $169.2M | ||
| Q4 24 | $270.3M | $174.1M | ||
| Q3 24 | $329.7M | $154.9M | ||
| Q2 24 | $321.8M | $154.1M |
净利润ASBRGEN
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | $13.3M | ||
| Q3 25 | $124.7M | $14.9M | ||
| Q2 25 | $111.2M | $14.9M | ||
| Q1 25 | $101.7M | $5.8M | ||
| Q4 24 | $-161.6M | $-30.3M | ||
| Q3 24 | $88.0M | $-654.0K | ||
| Q2 24 | $115.6M | $3.3M |
毛利率ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | 9.0% | ||
| Q3 25 | 50.5% | 8.9% | ||
| Q2 25 | 46.5% | 7.6% | ||
| Q1 25 | 42.3% | 3.9% | ||
| Q4 24 | -65.8% | -17.7% | ||
| Q3 24 | 32.8% | -5.1% | ||
| Q2 24 | 32.0% | 1.0% |
净利率ASBRGEN
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | 6.7% | ||
| Q3 25 | 40.9% | 7.9% | ||
| Q2 25 | 37.1% | 8.2% | ||
| Q1 25 | 35.6% | 3.4% | ||
| Q4 24 | -59.8% | -17.4% | ||
| Q3 24 | 26.7% | -0.4% | ||
| Q2 24 | 35.9% | 2.2% |
每股收益（稀释后）ASBRGEN
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | $0.24 | ||
| Q3 25 | $0.73 | $0.26 | ||
| Q2 25 | $0.65 | $0.26 | ||
| Q1 25 | $0.59 | $0.10 | ||
| Q4 24 | $-1.10 | $-0.55 | ||
| Q3 24 | $0.56 | $-0.01 | ||
| Q2 24 | $0.74 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $5.0B | $2.1B |
| 总资产 | $45.6B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $542.2M | ||
| Q3 25 | $594.1M | $537.9M | ||
| Q2 25 | $593.5M | — | ||
| Q1 25 | $591.4M | — | ||
| Q4 24 | $1.4B | $525.6M | ||
| Q3 24 | $844.3M | — | ||
| Q2 24 | $536.1M | — |
股东权益ASBRGEN
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $2.1B | ||
| Q3 25 | $4.9B | $2.1B | ||
| Q2 25 | $4.8B | $2.1B | ||
| Q1 25 | $4.7B | $2.0B | ||
| Q4 24 | $4.6B | $2.0B | ||
| Q3 24 | $4.4B | $2.0B | ||
| Q2 24 | $4.2B | $2.0B |
总资产ASBRGEN
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | $2.9B | ||
| Q3 25 | $44.5B | $2.9B | ||
| Q2 25 | $44.0B | $2.9B | ||
| Q1 25 | $43.3B | $2.9B | ||
| Q4 24 | $43.0B | $2.8B | ||
| Q3 24 | $42.2B | $2.8B | ||
| Q2 24 | $41.6B | $2.9B |
负债/权益比ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | 0.26× | ||
| Q3 25 | 0.12× | 0.26× | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.31× | 0.27× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | $25.7M | ||
| Q3 25 | $158.0M | $48.1M | ||
| Q2 25 | $141.5M | $28.6M | ||
| Q1 25 | $98.2M | $15.0M | ||
| Q4 24 | $207.1M | $39.2M | ||
| Q3 24 | $105.1M | $49.3M | ||
| Q2 24 | $113.5M | $42.2M |
自由现金流ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率ASBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | 1.93× | ||
| Q3 25 | 1.27× | 3.23× | ||
| Q2 25 | 1.27× | 1.92× | ||
| Q1 25 | 0.97× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 0.98× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
RGEN
暂无分部数据
